相关实验视频
Updated: Jun 20, 2025

08:06
Mixed Reality Assisted Radical Endoscopic Thyroidectomy
Published on: January 31, 2025
230
对考虑长期抗甲状腺药物治疗格雷夫斯病的患者的方法
Fereidoun Azizi1, Ladan Mehran1, Hengameh Abdi1
1Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran 1985717413, I.R.Iran.
The Journal of clinical endocrinology and metabolism
|July 17, 2024
概括
长期抗甲状腺药物 (ATD) 治疗,通常超过5年,对于管理Graves的甲状腺功能障碍和预防复发是有效的. 延长治疗确保了持续的甲状腺功能减退症和患者更高的缓解率.
科学领域:
- 内分泌学 在内分泌学.
- 内部医学 内部医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 全球范围内,抗甲状腺药物 (ATD) 是格雷夫斯甲状腺功能障碍的主要治疗方法.
- 传统的ATD治疗 (12-18个月) 经常导致甲状腺功能障碍复发.
- 长期的ATD (LT-ATD) 治疗在维持类甲状腺症方面显示出有效性和安全性.
研究的目的:
- 为了确定Graves甲状腺功能障碍症中ATD退出的最佳时间.
- 为了指导复发性甲状腺功能障碍症的管理策略.
- 审查LT-ATD协议并建议终身治疗方法.
主要方法:
- 关于长期ATD有效性和安全性的研究的综述.
- 在ATD治疗期间对TSH受体抗体动态的分析.
- 讨论关于治疗持续时间和缓解率的临床试验数据.
主要成果:
- 血清TSH受体抗体可能需要5-6年的ATD治疗才能永久减少.
- 长达5年或更长的治疗持续时间与高缓解率有关,在Graves的甲状腺功能障碍症.
- LT-ATD是有效和安全的维持euthyroid状态.
结论:
- 传统的ATD持续时间往往不足,导致复发率高.
- 长期的ATD治疗 (≥5年) 改善了格雷夫斯甲状腺功能障碍的缓解率.
- 个性化管理策略,包括潜在的终身ATD治疗,至关重要.
相关概念视频
Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Psychosis: Goals of Pharmacotherapy
114
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
114
Diabetes: Management and Pharmacotherapy
256
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
256
Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.0K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
156
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156

